Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index
19 mars 2021 16h05 HE
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, March 19, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...